The Danish Nonmelanoma Skin Cancer Dermatology Database
Authors Lamberg AL, Sølvsten H, Lei U, Vinding GR, Stender IM, Jemec GB, Vestergaard T, Thormann H, Hædersdal M, Dam TN, Olesen AB
Received 17 November 2015
Accepted for publication 17 February 2016
Published 25 October 2016 Volume 2016:8 Pages 633—636
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 2
Editor who approved publication: Professor Henrik Toft Sørensen
Anna Lei Lamberg,1 Henrik Sølvsten,2 Ulrikke Lei,3 Gabrielle Randskov Vinding,3 Ida Marie Stender,4 Gregor Borut Ernst Jemec,5 Tine Vestergaard,6 Henrik Thormann,7 Merete Hædersdal,8 Tomas Norman Dam,9 Anne Braae Olesen10
1Dermatology Clinic, Grenaa, Central Denmark Region, 2Dermatology Clinic, Aalborg, North Denmark Region, 3Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Gentofte, 4Dermatology Clinic, Charlottenlund, Capital Region of Denmark, 5Department of Dermatology, Roskilde Hospital, Health Sciences Faculty, University of Copenhagen, Roskilde, Zealand Region, 6Department of Dermatology, Odense University Hospital, Odense, 7Dermatology Clinic, Vejle, Region of Southern Denmark, 8Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Capital Region of Denmark, 9Dermatology Clinic, Nykøbing Falster, Zealand Region, 10Department of Dermatology, University Hospital of Aarhus, Aarhus, Central Denmark Region, Denmark
Aim of database: The Danish Nonmelanoma Skin Cancer Dermatology Database was established in 2008. The aim of this database was to collect data on nonmelanoma skin cancer (NMSC) treatment and improve its treatment in Denmark. NMSC is the most common malignancy in the western countries and represents a significant challenge in terms of public health management and health care costs. However, high-quality epidemiological and treatment data on NMSC are sparse.
Study population: The NMSC database includes patients with the following skin tumors: basal cell carcinoma (BCC), squamous cell carcinoma, Bowen's disease, and keratoacanthoma diagnosed by the participating office-based dermatologists in Denmark.
Main variables: Clinical and histological diagnoses, BCC subtype, localization, size, skin cancer history, skin phototype, and evidence of metastases and treatment modality are the main variables in the NMSC database. Information on recurrence, cosmetic results, and complications are registered at two follow-up visits at 3 months (between 0 and 6 months) and 12 months (between 6 and 15 months) after treatment.
Descriptive data: In 2014, 11,522 patients with 17,575 tumors were registered in the database. Of tumors with a histological diagnosis, 13,571 were BCCs, 840 squamous cell carcinomas, 504 Bowen's disease, and 173 keratoakanthomas.
Conclusion: The NMSC database encompasses detailed information on the type of tumor, a variety of prognostic factors, treatment modalities, and outcomes after treatment. The database has revealed that overall, the quality of care of NMSC in Danish dermatological clinics is high, and the database provides the necessary data for continuous quality assurance.
Keywords: nonmelanoma skin cancer, basal cell carcinoma, squamous cell carcinoma, epidemiology, treatment
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]